CS logo
small CS logo
SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung

Wien, Austria
Hospital in Vienna
Baumgartner Höhe 1, 1140 Wien

About SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Gilead Sciences
2
Total Rows: 2

Clinical Trials at SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung


During the past decade, SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111003311000000110000Started TrialsCompleted Trails20162017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2010-04-01
2014-09-01
Completed
708
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2010-04-01
2015-04-01
Completed
698
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
2016-06-07
2022-07-07
Completed
403
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
2017-09-20
2030-03-06
Active, not recruiting
382
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
2018-04-24
2025-01-19
Active, not recruiting
453
A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
2020-02-04
2024-03-21
Active, not recruiting
490
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
2020-08-24
2027-12-30
Active, not recruiting
800

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7Gilead Sciences: 2Gilead Sciences: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung


According to Clinical.Site data, the most researched conditions in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" are "HIV" (2 trials), "HIV Infections" (2 trials), "Cancer" (1 trials), "NSCLC" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" in a lesser frequency.

Clinical Trials Intervention Types at SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung


Most popular intervention types in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Carboplatin" (3 trials), "Tiragolumab" (3 trials), "ATV" (2 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (2 trials). Other intervention names were less common.

Clinical Trials Genders at SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung


The vast majority of trials in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung" are 9 trials for "All" genders.

Clinical Trials Status at SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung


Currently, there are NaN active trials in "SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SMZ - Baumgartner Hohe, Otto-Wagner-Spital; 2.Interne Lungenabteilung, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 4Active, not recruiting: 4Completed: 3Completed: 3Recruiting: 2Recruiting: 2